1. Usefulness of Percutaneous Transluminal Pulmonary Artery Balloon Angioplasty after Bilateral Pulmonary Artery Banding: Prevention against Additional Surgical Interventions
- Author
-
Takashi Miyamoto, Kimiko Nakajima, Kensuke Tanaka, Kentaro Ikeda, Shinya Shimoyama, Yoichiro Ishii, Hirokazu Arakawa, Tomio Kobayashi, and Mitsuru Seki
- Subjects
medicine.medical_specialty ,Interventional cardiology ,business.industry ,medicine.medical_treatment ,Balloon catheter ,Balloon ,medicine.disease ,Pulmonary artery banding ,Surgery ,Hypoplastic left heart syndrome ,medicine.anatomical_structure ,Internal medicine ,medicine.artery ,Ductus arteriosus ,Angioplasty ,Pulmonary artery ,medicine ,Cardiology ,business - Abstract
Objectives: We evaluated the efficacy of balloon dilatation after bilateral pulmonary artery banding for the treatment of severe congenital heart disease that depends on patent ductus arteriosus for systemic circulation. Background: Neonatal cardiopulmonary bypass can cause brain injury, which may result in a severely impaired neurodevelopmental outcome. Hence, we perform bilateral pulmonary artery banding combined with postoperative percutaneous trans catheter angioplasty with balloon dilatation as first-stage palliation. Methods: From October 2007 to December 2013, 27 consecutive patients underwent bilateral pulmonary artery banding at our institution. We retrospectively obtained their diagnostic, clinical, and catheter examination data from the medical records. Results: Bilateral pulmonary artery banding was performed at a median of 7 days. Among the 27 patients, 16 underwent expansive angioplasty using a balloon catheter at each banding site to increase pulmonary blood flow. The mean age at dilatation was 53.4 ± 25.9 days, and the mean pulmonary artery index significantly increased from 130.6 mm2/m2 ± 51.1 mm2/m2 before dilatation to 243.6 mm2/ m2 ± 93.5 mm2/m2 after dilatation (p
- Published
- 2017
- Full Text
- View/download PDF